[1] 王海涛, 张抗怀, 刘娜, 等. 临床药师对ICU潜在药物相互作用的鉴别和药学干预[J]. 中国医院药学杂志, 2018, 38(16):1747-1749.
[2] 方欢, 曾宏辉, 方忠宏, 等. 临床常见和重要的药物与药物间相互作用[J]. 中国医院用药评价与分析, 2013, 13(3):283-286.
[3] MORIYAMA B, OBENG A O, BARBARINO J, et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelin-es for CYP2C19 and voriconazole therapy[J]. Clin Pharmacol Ther,2017,102(1):45-51. doi:  10.1002/cpt.583
[4] 王亚妮. 异基因造血干细胞移植患者环孢素A和伏立康唑的治疗药物监测[J]. 宁夏:宁夏医科大学, 2020. doi:  10.27258/d.cnki.gnxyc.2020.000051
[5] ULLMANN A J, AGUADO J M, ARIKAN-AKDAGLI S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline[J]. Clin Microbiol Infect, 2018, 24(Suppl 1): e1-e38.
[6] CHEN K, ZHANG X L, KE X Y, et al. Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, Chinese pharmacological society[J]. Ther Drug Monit,2018,40(6):663-674. doi:  10.1097/FTD.0000000000000561
[7] DOLTON M J, MCLACHLAN A J. Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity[J]. Int J Antimicrob Agents,2014,44(3):183-193. doi:  10.1016/j.ijantimicag.2014.05.019
[8] MELLINGHOFF S C, PANSE J, ALAKEL N, et al. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)[J]. Ann Hematol,2018,97(2):197-207. doi:  10.1007/s00277-017-3196-2
[9] 孙鲁宁, 吴春勇, 赵舜波, 等. 药物对人肝CYP450酶诱导和抑制作用体外评价体系的建立与验证[J]. 药学学报, 2017, 52(12):1924-1932.
[10] 吴劲东, 仇锦春, 张永. 环孢素联用伏立康唑致再生障碍性贫血患儿血压持续升高的药学监护[J]. 医药导报, 2017, 36(12):1419-1421.
[11] ROMERO A J, POGAMP P L, NILSSON L G, et al. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients[J]. Clin Pharmacol Ther,2002,71(4):226-234. doi:  10.1067/mcp.2002.121911
[12] MASOUMI H T, HADJIBABAIE M, VAEZI M, et al. Evaluation of the interaction of intravenous and oral voriconazole with oral cyclosporine in Iranian HSCT patients[J]. J Res Pharm Pract,2017,6(2):77-82. doi:  10.4103/jrpp.JRPP_16_163